Clinical Trial Update: The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of SCT510A in wet age-related macular degeneration is listed with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• SCT510A

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Wet Age-related Macular Degeneration | Phase 1, Phase 2 | Status: UNKNOWN